tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Astec LifeSciences Re-appoints Nandkumar Dhekne as Independent Director

Story Highlights
Astec LifeSciences Re-appoints Nandkumar Dhekne as Independent Director

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Astec Lifesciences Limited ( (IN:ASTEC) ) just unveiled an update.

Astec LifeSciences Limited has announced the re-appointment of Mr. Nandkumar Dhekne as a Non-Executive & Independent Director for a second term of five years, starting from December 18, 2025, to December 17, 2030, pending shareholder approval. Mr. Dhekne brings extensive experience in field services, operations management, and sales, having held senior leadership roles across the Asia Pacific region, which is expected to bolster Astec’s strategic direction and governance.

More about Astec Lifesciences Limited

Average Trading Volume: 2,086

Technical Sentiment Signal: Sell

Current Market Cap: 17.93B INR

For a thorough assessment of ASTEC stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1